Healthify merges with US nutrition-care platform Berry Street in all-stock deal
Bengaluru-based Healthify has merged with Berry Street, combining its AI health platform with Berry Street’s insurance-backed network of more than 2,000 clinicians across all 50 US states. The combined company will use the Healthify brand in India and international markets.
What happened
Bengaluru-based Healthify merged with US nutrition-care company Berry Street in an all-stock deal, combining Healthify’s AI health platform with Berry Street’s
Key facts
- All-stock deal
- More than 2,000 clinicians
- 50 US states
- Founded in 2012
- Around $150 million raised
Why this matters
The deal illustrates how health-tech platforms can use clinician-network acquisitions to accelerate US market entry, reimbursement access, and care-delivery capabilities without building regulated infrastructure from scratch.
What to watch
- New or expanded US payer, employer or health-system contracts.
- Evidence that Healthify features are embedded in Berry Street's clinician workflow rather than offered as a separate app.
- Changes in Berry Street clinician count, patient volumes, reimbursement rates and dietitian utilization.
- US regulatory, HIPAA, data-localization and AI clinical-decision-support disclosures.
- Partnerships with GLP-1 prescribers, pharmacies, diabetes-care vendors or obesity-management platforms.
- Follow-on funding, valuation signals or a US operating headquarters announcement.
- Launch Healthify AI tools for Berry Street clinicians and patients, with US privacy and clinical-governance controls.
- Use Berry Street's payer credentials to pursue reimbursement contracts for obesity, diabetes, PCOS and GLP-1 nutrition-support programs.
- Package dietitian access with Healthify's consumer engagement products for employers and health plans.
- Maintain distinct India/international branding while deciding whether Berry Street's US brand should remain customer-facing.
- Prioritize outcomes studies showing engagement, adherence, clinician capacity gains and medical-cost impact.